Correlation Between Aquestive Therapeutics and 571903BH5

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and 571903BH5 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and 571903BH5 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and MAR 275 15 OCT 33, you can compare the effects of market volatilities on Aquestive Therapeutics and 571903BH5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of 571903BH5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and 571903BH5.

Diversification Opportunities for Aquestive Therapeutics and 571903BH5

0.32

Correlation Coefficient

Aquestive Therapeutics  571903BH5

Weak diversification

The 3 months correlation between Aquestive and 571903BH5 is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and MAR 275 15 OCT 33 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAR 275 15 and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with 571903BH5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAR 275 15 has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and 571903BH5 go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and 571903BH5

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 6.68 times more return on investment than 571903BH5. However, Aquestive Therapeutics is 6.68 times more volatile than MAR 275 15 OCT 33. It trades about 0.09 of its potential returns per unit of risk. MAR 275 15 OCT 33 is currently generating about 0.09 per unit of risk. If you would invest  245.00  in Aquestive Therapeutics on September 29, 2024 and sell it today you would earn a total of  107.00  from holding Aquestive Therapeutics or generate 43.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Aquestive Therapeutics  vs.  MAR 275 15 OCT 33

Aquestive Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

MAR 275 15

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MAR 275 15 OCT 33 are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 571903BH5 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Aquestive Therapeutics and 571903BH5

The main advantage of trading using opposite Aquestive Therapeutics and 571903BH5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, 571903BH5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 571903BH5 will offset losses from the drop in 571903BH5's long position.

The idea behind Aquestive Therapeutics and MAR 275 15 OCT 33 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.